SpacePharma

SpacePharma develops miniaturized, automated laboratories for conducting scientific experiments in microgravity conditions in space.

Aerospace, Defense & HLS
Active
Series A Herzliya, Israel Founded 2012
Website ↗ LinkedIn
Last updated 2026-07-26
Total raised
$68.5M
Last: Grant 2024-03
Stage
Series A
Founded
2012
Headcount
20
HQ
Herzliya, Israel
Sector
Aerospace, Defense & HLS

About

SpacePharma is a Swiss-Israeli biotechnology company that specializes in enabling pharmaceutical, biological, and materials science experiments in microgravity environments using miniaturized, autonomous laboratories deployed on satellites, suborbital flights, and the International Space Station (ISS). The company's core mission is to harness microgravity to unlock new insights into drug crystallization, protein folding, organ-on-a-chip modeling, and disease mechanisms, ultimately accelerating the development of novel therapeutics. SpacePharma offers end-to-end services for microgravity research, including experiment planning, preparation, execution, and data analysis. They have developed technologies like the SPAd platform for microfluidic experiments and the SPACTORY system for automated, scalable crystallization in space.

Funding history · 12 rounds · $68.5M total

2026-05
F Round $17.6M
★ A-Labs★ European Union★ Innovation Authority★ European Innovation Council★ Business in Space Growth Network
2025
E Round $2.5M
2024-12
Grant $8.1M
★ Horizon Europe★ European Innovation Council★ European Innovation Council (EIC) Accelerator★ European Union (Horizon Europe)★ Horizon Europe program (part of the European Union)EICA-LabsEuropean UnionEIC AcceleratorInnovation AuthorityHorizon Europe programBusiness in Space Growth NetworkHorizon Europe program's accelerator
2024-03
Grant $2.2M
★ European Innovation Council★ European Innovation Council (EIC) AcceleratorA-LabsEuropean UnionEIC AcceleratorInnovation AuthorityConfidential investorBusiness in Space Growth NetworkHorizon Europe program's acceleratorHorizon Europe program (part of the European Union)European Innovation Council (EIC) Accelerator program
2022-08
D Round Undisclosed
2021-02
C Round $10.0M
★ European Innovation Council Fund
2019-11
Grant Undisclosed
★ Space Florida★ Israel Innovation Authority★ Space Florida-Israel Innovation Partnership ProgramCadW Therapeutics/Moffitt Cancer Center (partner)
2018-07
B Round $10.0M
★ State of Mind Ventures
2017-07
Grant Undisclosed
★ Space Florida★ One unnamed investor★ Israel Innovation Authority
2016-02
Grant $8.1M
★ Europa★ Horizon Europe
2015-10
A Round $5.0M
★ State of Mind Ventures
2015-01
Seed $5.0M
★ European Union★ Innovation Authority★ State of Mind VenturesA-LabsEuropean Innovation CouncilBusiness in Space Growth Network

Headcount over time

From 15 (2018-09) to 24 (2026-03) · +9 (+60%) · 31 points · source: Finder history + radar grounding
250 2018-09 2026-03

Q&A

What is SpacePharma's primary business?
SpacePharma develops miniaturized, automated laboratories for conducting scientific experiments in microgravity conditions in space, focusing on pharmaceutical, biological, and materials science research.
When was SpacePharma founded?
SpacePharma was founded in 2012.
How much funding has SpacePharma raised in total?
SpacePharma has raised a total of $19,980,000 USD.
What was SpacePharma's most recent funding event?
In March 2024, SpacePharma received a Grant of $2,000,000 USD from the European Innovation Council.
Who are the co-founders of SpacePharma?
The co-founders of SpacePharma are Yossi Yamin (Co-Founder & CEO) and Martin Aebi (Co-Founder & General Manager).
What is the current employee count for SpacePharma?
SpacePharma has 20 employees, falling within the 11-50 employee bucket.
Where are SpacePharma's main offices located?
SpacePharma has offices in Herzliya, Israel (HQ), Merritt Island, Florida, USA, Courgenay, Switzerland, and Palo Alto, CA, USA.
What is the SPANCER project that SpacePharma is collaborating on?
In December 2024, SpacePharma, BSGN (Business in Space Growth Network), and Roche are collaborating on SPANCER, a project utilizing SpacePharma's microgravity labs to create consistent, high-quality 3D human tissues for cancer diagnostics and treatments, supported by ESA's BSGN accelerator program.
What is the PRICILIA program that SpacePharma is involved with?
In December 2025, SpacePharma was part of the second cohort of ESA's Life Science Accelerator, which includes the PRICILIA program targeting valuable drug discovery and development in microgravity in.

Team · 2

Yossi Yamin
Founder · Co-Founder & CEO
Martin Aebi
Founder · Co-Founder & General Manager

Sectors & technology

Primary sector
Aerospace, Defense & HLS
Sub-sectors
Aerospace, Defense & HLSSpace TechSpace Components and InfraHealth Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Simulation & Imaging
Target customers
Industrial ManufacturingDiscrete IndustriesAerospaceHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2GB2B

Highlights

Verified

Tags

simulationlaboratoriesbiotechnologypharmaceuticalsaerospacepharma-companiesantibodiesmicrobiologyspace-techcancerstem-cells
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitespacepharma.health
LinkedInlinkedin.com/company/10408185
Facebookfacebook.com/Spacepharma
YouTubeyoutube.com/user/SpacePharma

Identifiers & details

Founded2012
Employees (exact)20
OfficesMerritt Island; Courgenay; Palo Alto; United Kingdom

Radar intelligence

Patents

EPO5

Publications (Crossref)

Works1

Web history (Wayback)

Domainspacepharma.health

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514884238
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2013-06-03
Purposeלעסוק בסוגי עיסוק שפורטו בתקנון
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events0
Registered addressשד אבא אבן 1 הרצליה